ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-23P15213
Home | Market Reports | Health| Health Conditions
Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Research Report 2023
BUY CHAPTERS

Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Research Report 2025

Code: QYRE-Auto-23P15213
Report
February 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Beijing Tongrentang
Tasly Pharmaceutical
Shaanxi Buchang Pharmaceutical
Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited
Dr. Willmar Schwabe GmbH & Co. KG
Shanxi Guang Yu Yuan Limited Company of Chinese Medicine
KPC Pharmaceuticals
Sinopharm Zhijun
Shijiazhuang Yiling Pharmaceutical
Shanxi Liye Pharmaceutical
Shineway Pharmaceutical
Guangzhou Baiyunshan Xingqun Pharmaceutical
Jilin Xingxing Technology Pharmaceutical
Sinopharm Zhonglian Pharmaceutical
Beijing Peking University WBL Biotech
Yunnan Weihe Pharmaceuticals
Guangxi Wuzhou Pharmaceuticals (GROUP)
SPH NO.1 Biochemical & Pharmaceutical
Chengdu Baiyu Pharmaceutical
Shanghai Greenvalley Pharmaceutical
Shanghai Hutchison Pharmaceuticals

Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Size

The global market for Cardiovascular and Cerebrovascular Chinese Patent Medicine was valued at US$ 12330 million in the year 2024 and is projected to reach a revised size of US$ 21250 million by 2031, growing at a CAGR of 8.2% during the forecast period.

Cardiovascular and Cerebrovascular Chinese Patent Medicine Market

Cardiovascular and Cerebrovascular Chinese Patent Medicine Market

Cardiovascular and cerebrovascular Chinese patent medicines refer to Chinese patent medicines for the treatment of various cardiovascular and cerebrovascular diseases such as coronary heart disease, cerebral apoplexy, myocardial infarction, arrhythmia, angina pectoris and hypertension, including oral Chinese patent medicines, traditional Chinese medicine injections and other dosage forms. product.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cardiovascular and Cerebrovascular Chinese Patent Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular and Cerebrovascular Chinese Patent Medicine.
The Cardiovascular and Cerebrovascular Chinese Patent Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardiovascular and Cerebrovascular Chinese Patent Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiovascular and Cerebrovascular Chinese Patent Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Report

Report Metric Details
Report Name Cardiovascular and Cerebrovascular Chinese Patent Medicine Market
Accounted market size in year US$ 12330 million
Forecasted market size in 2031 US$ 21250 million
CAGR 8.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Oral
  • Injection
Segment by Application
  • Hospital
  • Pharmacy
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Beijing Tongrentang, Tasly Pharmaceutical, Shaanxi Buchang Pharmaceutical, Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited, Dr.Willmar Schwabe GmbH & Co. KG, Shanxi Guang Yu Yuan Limited Company of Chinese Medicine, KPC Pharmaceuticals, Sinopharm Zhijun, Shijiazhuang Yiling Pharmaceutical, Shanxi Liye Pharmaceutical, Shineway Pharmaceutical, Guangzhou Baiyunshan Xingqun Pharmaceutical, Jilin Xingxing Technology Pharmaceutical, Sinopharm Zhonglian Pharmaceutical, Beijing Peking University WBL Biotech, Yunnan Weihe Pharmaceuticals, Guangxi Wuzhou Pharmaceuticals (GROUP), SPH NO.1 Biochemical & Pharmaceutical, Chengdu Baiyu Pharmaceutical, Shanghai Greenvalley Pharmaceutical, Shanghai Hutchison Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cardiovascular and Cerebrovascular Chinese Patent Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cardiovascular and Cerebrovascular Chinese Patent Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Cardiovascular and Cerebrovascular Chinese Patent Medicine Market growing?

Ans: The Cardiovascular and Cerebrovascular Chinese Patent Medicine Market witnessing a CAGR of 8.2% during the forecast period 2025-2031.

What is the Cardiovascular and Cerebrovascular Chinese Patent Medicine Market size in 2031?

Ans: The Cardiovascular and Cerebrovascular Chinese Patent Medicine Market size in 2031 will be US$ 21250 million.

Who are the main players in the Cardiovascular and Cerebrovascular Chinese Patent Medicine Market report?

Ans: The main players in the Cardiovascular and Cerebrovascular Chinese Patent Medicine Market are Beijing Tongrentang, Tasly Pharmaceutical, Shaanxi Buchang Pharmaceutical, Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited, Dr.Willmar Schwabe GmbH & Co. KG, Shanxi Guang Yu Yuan Limited Company of Chinese Medicine, KPC Pharmaceuticals, Sinopharm Zhijun, Shijiazhuang Yiling Pharmaceutical, Shanxi Liye Pharmaceutical, Shineway Pharmaceutical, Guangzhou Baiyunshan Xingqun Pharmaceutical, Jilin Xingxing Technology Pharmaceutical, Sinopharm Zhonglian Pharmaceutical, Beijing Peking University WBL Biotech, Yunnan Weihe Pharmaceuticals, Guangxi Wuzhou Pharmaceuticals (GROUP), SPH NO.1 Biochemical & Pharmaceutical, Chengdu Baiyu Pharmaceutical, Shanghai Greenvalley Pharmaceutical, Shanghai Hutchison Pharmaceuticals

What are the Application segmentation covered in the Cardiovascular and Cerebrovascular Chinese Patent Medicine Market report?

Ans: The Applications covered in the Cardiovascular and Cerebrovascular Chinese Patent Medicine Market report are Hospital, Pharmacy, Clinic

What are the Type segmentation covered in the Cardiovascular and Cerebrovascular Chinese Patent Medicine Market report?

Ans: The Types covered in the Cardiovascular and Cerebrovascular Chinese Patent Medicine Market report are Oral, Injection

Recommended Reports

Cardiovascular Drugs

Stroke & Cerebrovascular

Chinese Patent Medicine

1 Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Overview
1.1 Product Definition
1.2 Cardiovascular and Cerebrovascular Chinese Patent Medicine by Type
1.2.1 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Injection
1.3 Cardiovascular and Cerebrovascular Chinese Patent Medicine by Application
1.3.1 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinic
1.4 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Size Estimates and Forecasts
1.4.1 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue 2020-2031
1.4.2 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales 2020-2031
1.4.3 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Competition by Manufacturers
2.1 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cardiovascular and Cerebrovascular Chinese Patent Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cardiovascular and Cerebrovascular Chinese Patent Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiovascular and Cerebrovascular Chinese Patent Medicine, Product Type & Application
2.7 Global Key Manufacturers of Cardiovascular and Cerebrovascular Chinese Patent Medicine, Date of Enter into This Industry
2.8 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Competitive Situation and Trends
2.8.1 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cardiovascular and Cerebrovascular Chinese Patent Medicine Players Market Share by Revenue
2.8.3 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Scenario by Region
3.1 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Region: 2020-2031
3.2.1 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Region: 2020-2025
3.2.2 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Region: 2026-2031
3.3 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Region: 2020-2031
3.3.1 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Region: 2020-2025
3.3.2 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Region: 2026-2031
3.4 North America Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Facts & Figures by Country
3.4.1 North America Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Country (2020-2031)
3.4.3 North America Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Facts & Figures by Country
3.5.1 Europe Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Country (2020-2031)
3.5.3 Europe Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Region (2020-2031)
3.6.3 Asia Pacific Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Facts & Figures by Country
3.7.1 Latin America Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Country (2020-2031)
3.7.3 Latin America Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Type (2020-2031)
4.1.1 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Type (2020-2025)
4.1.2 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Type (2026-2031)
4.1.3 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Type (2020-2031)
4.2 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Type (2020-2031)
4.2.1 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Type (2020-2025)
4.2.2 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Type (2026-2031)
4.2.3 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Market Share by Type (2020-2031)
4.3 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Application (2020-2031)
5.1.1 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Application (2020-2025)
5.1.2 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Application (2026-2031)
5.1.3 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Application (2020-2031)
5.2 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Application (2020-2031)
5.2.1 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Application (2020-2025)
5.2.2 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Application (2026-2031)
5.2.3 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Market Share by Application (2020-2031)
5.3 Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Beijing Tongrentang
6.1.1 Beijing Tongrentang Company Information
6.1.2 Beijing Tongrentang Description and Business Overview
6.1.3 Beijing Tongrentang Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Beijing Tongrentang Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.1.5 Beijing Tongrentang Recent Developments/Updates
6.2 Tasly Pharmaceutical
6.2.1 Tasly Pharmaceutical Company Information
6.2.2 Tasly Pharmaceutical Description and Business Overview
6.2.3 Tasly Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Tasly Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.2.5 Tasly Pharmaceutical Recent Developments/Updates
6.3 Shaanxi Buchang Pharmaceutical
6.3.1 Shaanxi Buchang Pharmaceutical Company Information
6.3.2 Shaanxi Buchang Pharmaceutical Description and Business Overview
6.3.3 Shaanxi Buchang Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shaanxi Buchang Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.3.5 Shaanxi Buchang Pharmaceutical Recent Developments/Updates
6.4 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited
6.4.1 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Company Information
6.4.2 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Description and Business Overview
6.4.3 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.4.5 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Recent Developments/Updates
6.5 Dr.Willmar Schwabe GmbH & Co. KG
6.5.1 Dr.Willmar Schwabe GmbH & Co. KG Company Information
6.5.2 Dr.Willmar Schwabe GmbH & Co. KG Description and Business Overview
6.5.3 Dr.Willmar Schwabe GmbH & Co. KG Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dr.Willmar Schwabe GmbH & Co. KG Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.5.5 Dr.Willmar Schwabe GmbH & Co. KG Recent Developments/Updates
6.6 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine
6.6.1 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Company Information
6.6.2 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Description and Business Overview
6.6.3 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.6.5 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Recent Developments/Updates
6.7 KPC Pharmaceuticals
6.7.1 KPC Pharmaceuticals Company Information
6.7.2 KPC Pharmaceuticals Description and Business Overview
6.7.3 KPC Pharmaceuticals Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 KPC Pharmaceuticals Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.7.5 KPC Pharmaceuticals Recent Developments/Updates
6.8 Sinopharm Zhijun
6.8.1 Sinopharm Zhijun Company Information
6.8.2 Sinopharm Zhijun Description and Business Overview
6.8.3 Sinopharm Zhijun Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sinopharm Zhijun Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.8.5 Sinopharm Zhijun Recent Developments/Updates
6.9 Shijiazhuang Yiling Pharmaceutical
6.9.1 Shijiazhuang Yiling Pharmaceutical Company Information
6.9.2 Shijiazhuang Yiling Pharmaceutical Description and Business Overview
6.9.3 Shijiazhuang Yiling Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shijiazhuang Yiling Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.9.5 Shijiazhuang Yiling Pharmaceutical Recent Developments/Updates
6.10 Shanxi Liye Pharmaceutical
6.10.1 Shanxi Liye Pharmaceutical Company Information
6.10.2 Shanxi Liye Pharmaceutical Description and Business Overview
6.10.3 Shanxi Liye Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shanxi Liye Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.10.5 Shanxi Liye Pharmaceutical Recent Developments/Updates
6.11 Shineway Pharmaceutical
6.11.1 Shineway Pharmaceutical Company Information
6.11.2 Shineway Pharmaceutical Description and Business Overview
6.11.3 Shineway Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shineway Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.11.5 Shineway Pharmaceutical Recent Developments/Updates
6.12 Guangzhou Baiyunshan Xingqun Pharmaceutical
6.12.1 Guangzhou Baiyunshan Xingqun Pharmaceutical Company Information
6.12.2 Guangzhou Baiyunshan Xingqun Pharmaceutical Description and Business Overview
6.12.3 Guangzhou Baiyunshan Xingqun Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Guangzhou Baiyunshan Xingqun Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.12.5 Guangzhou Baiyunshan Xingqun Pharmaceutical Recent Developments/Updates
6.13 Jilin Xingxing Technology Pharmaceutical
6.13.1 Jilin Xingxing Technology Pharmaceutical Company Information
6.13.2 Jilin Xingxing Technology Pharmaceutical Description and Business Overview
6.13.3 Jilin Xingxing Technology Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Jilin Xingxing Technology Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.13.5 Jilin Xingxing Technology Pharmaceutical Recent Developments/Updates
6.14 Sinopharm Zhonglian Pharmaceutical
6.14.1 Sinopharm Zhonglian Pharmaceutical Company Information
6.14.2 Sinopharm Zhonglian Pharmaceutical Description and Business Overview
6.14.3 Sinopharm Zhonglian Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sinopharm Zhonglian Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.14.5 Sinopharm Zhonglian Pharmaceutical Recent Developments/Updates
6.15 Beijing Peking University WBL Biotech
6.15.1 Beijing Peking University WBL Biotech Company Information
6.15.2 Beijing Peking University WBL Biotech Description and Business Overview
6.15.3 Beijing Peking University WBL Biotech Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Beijing Peking University WBL Biotech Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.15.5 Beijing Peking University WBL Biotech Recent Developments/Updates
6.16 Yunnan Weihe Pharmaceuticals
6.16.1 Yunnan Weihe Pharmaceuticals Company Information
6.16.2 Yunnan Weihe Pharmaceuticals Description and Business Overview
6.16.3 Yunnan Weihe Pharmaceuticals Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Yunnan Weihe Pharmaceuticals Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.16.5 Yunnan Weihe Pharmaceuticals Recent Developments/Updates
6.17 Guangxi Wuzhou Pharmaceuticals (GROUP)
6.17.1 Guangxi Wuzhou Pharmaceuticals (GROUP) Company Information
6.17.2 Guangxi Wuzhou Pharmaceuticals (GROUP) Description and Business Overview
6.17.3 Guangxi Wuzhou Pharmaceuticals (GROUP) Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Guangxi Wuzhou Pharmaceuticals (GROUP) Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.17.5 Guangxi Wuzhou Pharmaceuticals (GROUP) Recent Developments/Updates
6.18 SPH NO.1 Biochemical & Pharmaceutical
6.18.1 SPH NO.1 Biochemical & Pharmaceutical Company Information
6.18.2 SPH NO.1 Biochemical & Pharmaceutical Description and Business Overview
6.18.3 SPH NO.1 Biochemical & Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 SPH NO.1 Biochemical & Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.18.5 SPH NO.1 Biochemical & Pharmaceutical Recent Developments/Updates
6.19 Chengdu Baiyu Pharmaceutical
6.19.1 Chengdu Baiyu Pharmaceutical Company Information
6.19.2 Chengdu Baiyu Pharmaceutical Description and Business Overview
6.19.3 Chengdu Baiyu Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Chengdu Baiyu Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.19.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
6.20 Shanghai Greenvalley Pharmaceutical
6.20.1 Shanghai Greenvalley Pharmaceutical Company Information
6.20.2 Shanghai Greenvalley Pharmaceutical Description and Business Overview
6.20.3 Shanghai Greenvalley Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Shanghai Greenvalley Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.20.5 Shanghai Greenvalley Pharmaceutical Recent Developments/Updates
6.21 Shanghai Hutchison Pharmaceuticals
6.21.1 Shanghai Hutchison Pharmaceuticals Company Information
6.21.2 Shanghai Hutchison Pharmaceuticals Description and Business Overview
6.21.3 Shanghai Hutchison Pharmaceuticals Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Shanghai Hutchison Pharmaceuticals Cardiovascular and Cerebrovascular Chinese Patent Medicine Product Portfolio
6.21.5 Shanghai Hutchison Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiovascular and Cerebrovascular Chinese Patent Medicine Industry Chain Analysis
7.2 Cardiovascular and Cerebrovascular Chinese Patent Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiovascular and Cerebrovascular Chinese Patent Medicine Production Mode & Process Analysis
7.4 Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales and Marketing
7.4.1 Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Channels
7.4.2 Cardiovascular and Cerebrovascular Chinese Patent Medicine Distributors
7.5 Cardiovascular and Cerebrovascular Chinese Patent Medicine Customer Analysis
8 Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Dynamics
8.1 Cardiovascular and Cerebrovascular Chinese Patent Medicine Industry Trends
8.2 Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Drivers
8.3 Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Challenges
8.4 Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Beijing Tongrentang
Tasly Pharmaceutical
Shaanxi Buchang Pharmaceutical
Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited
Dr. Willmar Schwabe GmbH & Co. KG
Shanxi Guang Yu Yuan Limited Company of Chinese Medicine
KPC Pharmaceuticals
Sinopharm Zhijun
Shijiazhuang Yiling Pharmaceutical
Shanxi Liye Pharmaceutical
Shineway Pharmaceutical
Guangzhou Baiyunshan Xingqun Pharmaceutical
Jilin Xingxing Technology Pharmaceutical
Sinopharm Zhonglian Pharmaceutical
Beijing Peking University WBL Biotech
Yunnan Weihe Pharmaceuticals
Guangxi Wuzhou Pharmaceuticals (GROUP)
SPH NO.1 Biochemical & Pharmaceutical
Chengdu Baiyu Pharmaceutical
Shanghai Greenvalley Pharmaceutical
Shanghai Hutchison Pharmaceuticals
List of Tables
 Table 1. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cardiovascular and Cerebrovascular Chinese Patent Medicine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cardiovascular and Cerebrovascular Chinese Patent Medicine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cardiovascular and Cerebrovascular Chinese Patent Medicine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cardiovascular and Cerebrovascular Chinese Patent Medicine, Product Type & Application
 Table 12. Global Key Manufacturers of Cardiovascular and Cerebrovascular Chinese Patent Medicine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular and Cerebrovascular Chinese Patent Medicine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Region (2020-2025)
 Table 19. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Region (2026-2031)
 Table 21. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Market Share by Region (2020-2025)
 Table 23. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Market Share by Region (2026-2031)
 Table 25. North America Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units) by Type (2020-2025)
 Table 51. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units) by Type (2026-2031)
 Table 52. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Type (2020-2025)
 Table 53. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Type (2026-2031)
 Table 54. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Market Share by Type (2020-2025)
 Table 57. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Market Share by Type (2026-2031)
 Table 58. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units) by Application (2020-2025)
 Table 61. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units) by Application (2026-2031)
 Table 62. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Application (2020-2025)
 Table 63. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Application (2026-2031)
 Table 64. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Market Share by Application (2020-2025)
 Table 67. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Market Share by Application (2026-2031)
 Table 68. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Price (US$/Unit) by Application (2026-2031)
 Table 70. Beijing Tongrentang Company Information
 Table 71. Beijing Tongrentang Description and Business Overview
 Table 72. Beijing Tongrentang Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Beijing Tongrentang Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 74. Beijing Tongrentang Recent Developments/Updates
 Table 75. Tasly Pharmaceutical Company Information
 Table 76. Tasly Pharmaceutical Description and Business Overview
 Table 77. Tasly Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Tasly Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 79. Tasly Pharmaceutical Recent Developments/Updates
 Table 80. Shaanxi Buchang Pharmaceutical Company Information
 Table 81. Shaanxi Buchang Pharmaceutical Description and Business Overview
 Table 82. Shaanxi Buchang Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Shaanxi Buchang Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 84. Shaanxi Buchang Pharmaceutical Recent Developments/Updates
 Table 85. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Company Information
 Table 86. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Description and Business Overview
 Table 87. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 89. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Recent Developments/Updates
 Table 90. Dr.Willmar Schwabe GmbH & Co. KG Company Information
 Table 91. Dr.Willmar Schwabe GmbH & Co. KG Description and Business Overview
 Table 92. Dr.Willmar Schwabe GmbH & Co. KG Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Dr.Willmar Schwabe GmbH & Co. KG Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 94. Dr.Willmar Schwabe GmbH & Co. KG Recent Developments/Updates
 Table 95. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Company Information
 Table 96. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Description and Business Overview
 Table 97. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 99. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Recent Developments/Updates
 Table 100. KPC Pharmaceuticals Company Information
 Table 101. KPC Pharmaceuticals Description and Business Overview
 Table 102. KPC Pharmaceuticals Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. KPC Pharmaceuticals Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 104. KPC Pharmaceuticals Recent Developments/Updates
 Table 105. Sinopharm Zhijun Company Information
 Table 106. Sinopharm Zhijun Description and Business Overview
 Table 107. Sinopharm Zhijun Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sinopharm Zhijun Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 109. Sinopharm Zhijun Recent Developments/Updates
 Table 110. Shijiazhuang Yiling Pharmaceutical Company Information
 Table 111. Shijiazhuang Yiling Pharmaceutical Description and Business Overview
 Table 112. Shijiazhuang Yiling Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Shijiazhuang Yiling Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 114. Shijiazhuang Yiling Pharmaceutical Recent Developments/Updates
 Table 115. Shanxi Liye Pharmaceutical Company Information
 Table 116. Shanxi Liye Pharmaceutical Description and Business Overview
 Table 117. Shanxi Liye Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Shanxi Liye Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 119. Shanxi Liye Pharmaceutical Recent Developments/Updates
 Table 120. Shineway Pharmaceutical Company Information
 Table 121. Shineway Pharmaceutical Description and Business Overview
 Table 122. Shineway Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Shineway Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 124. Shineway Pharmaceutical Recent Developments/Updates
 Table 125. Guangzhou Baiyunshan Xingqun Pharmaceutical Company Information
 Table 126. Guangzhou Baiyunshan Xingqun Pharmaceutical Description and Business Overview
 Table 127. Guangzhou Baiyunshan Xingqun Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Guangzhou Baiyunshan Xingqun Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 129. Guangzhou Baiyunshan Xingqun Pharmaceutical Recent Developments/Updates
 Table 130. Jilin Xingxing Technology Pharmaceutical Company Information
 Table 131. Jilin Xingxing Technology Pharmaceutical Description and Business Overview
 Table 132. Jilin Xingxing Technology Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Jilin Xingxing Technology Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 134. Jilin Xingxing Technology Pharmaceutical Recent Developments/Updates
 Table 135. Sinopharm Zhonglian Pharmaceutical Company Information
 Table 136. Sinopharm Zhonglian Pharmaceutical Description and Business Overview
 Table 137. Sinopharm Zhonglian Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Sinopharm Zhonglian Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 139. Sinopharm Zhonglian Pharmaceutical Recent Developments/Updates
 Table 140. Beijing Peking University WBL Biotech Company Information
 Table 141. Beijing Peking University WBL Biotech Description and Business Overview
 Table 142. Beijing Peking University WBL Biotech Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Beijing Peking University WBL Biotech Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 144. Beijing Peking University WBL Biotech Recent Developments/Updates
 Table 145. Yunnan Weihe Pharmaceuticals Company Information
 Table 146. Yunnan Weihe Pharmaceuticals Description and Business Overview
 Table 147. Yunnan Weihe Pharmaceuticals Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Yunnan Weihe Pharmaceuticals Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 149. Yunnan Weihe Pharmaceuticals Recent Developments/Updates
 Table 150. Guangxi Wuzhou Pharmaceuticals (GROUP) Company Information
 Table 151. Guangxi Wuzhou Pharmaceuticals (GROUP) Description and Business Overview
 Table 152. Guangxi Wuzhou Pharmaceuticals (GROUP) Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Guangxi Wuzhou Pharmaceuticals (GROUP) Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 154. Guangxi Wuzhou Pharmaceuticals (GROUP) Recent Developments/Updates
 Table 155. SPH NO.1 Biochemical & Pharmaceutical Company Information
 Table 156. SPH NO.1 Biochemical & Pharmaceutical Description and Business Overview
 Table 157. SPH NO.1 Biochemical & Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. SPH NO.1 Biochemical & Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 159. SPH NO.1 Biochemical & Pharmaceutical Recent Developments/Updates
 Table 160. Chengdu Baiyu Pharmaceutical Company Information
 Table 161. Chengdu Baiyu Pharmaceutical Description and Business Overview
 Table 162. Chengdu Baiyu Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Chengdu Baiyu Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 164. Chengdu Baiyu Pharmaceutical Recent Developments/Updates
 Table 165. Shanghai Greenvalley Pharmaceutical Company Information
 Table 166. Shanghai Greenvalley Pharmaceutical Description and Business Overview
 Table 167. Shanghai Greenvalley Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Shanghai Greenvalley Pharmaceutical Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 169. Shanghai Greenvalley Pharmaceutical Recent Developments/Updates
 Table 170. Shanghai Hutchison Pharmaceuticals Company Information
 Table 171. Shanghai Hutchison Pharmaceuticals Description and Business Overview
 Table 172. Shanghai Hutchison Pharmaceuticals Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Shanghai Hutchison Pharmaceuticals Cardiovascular and Cerebrovascular Chinese Patent Medicine Product
 Table 174. Shanghai Hutchison Pharmaceuticals Recent Developments/Updates
 Table 175. Key Raw Materials Lists
 Table 176. Raw Materials Key Suppliers Lists
 Table 177. Cardiovascular and Cerebrovascular Chinese Patent Medicine Distributors List
 Table 178. Cardiovascular and Cerebrovascular Chinese Patent Medicine Customers List
 Table 179. Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Trends
 Table 180. Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Drivers
 Table 181. Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Challenges
 Table 182. Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Restraints
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cardiovascular and Cerebrovascular Chinese Patent Medicine
 Figure 2. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Pharmacy
 Figure 10. Clinic
 Figure 11. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales (2020-2031) & (K Units)
 Figure 14. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Cardiovascular and Cerebrovascular Chinese Patent Medicine Report Years Considered
 Figure 16. Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Share by Manufacturers in 2024
 Figure 17. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Cardiovascular and Cerebrovascular Chinese Patent Medicine Players: Market Share by Revenue in Cardiovascular and Cerebrovascular Chinese Patent Medicine in 2024
 Figure 19. Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Country (2020-2031)
 Figure 22. North America Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Market Share by Region (2020-2031)
 Figure 34. China Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Cardiovascular and Cerebrovascular Chinese Patent Medicine Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Cardiovascular and Cerebrovascular Chinese Patent Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Cardiovascular and Cerebrovascular Chinese Patent Medicine by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Cardiovascular and Cerebrovascular Chinese Patent Medicine by Type (2020-2031)
 Figure 53. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Cardiovascular and Cerebrovascular Chinese Patent Medicine by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Cardiovascular and Cerebrovascular Chinese Patent Medicine by Application (2020-2031)
 Figure 56. Global Cardiovascular and Cerebrovascular Chinese Patent Medicine Price (US$/Unit) by Application (2020-2031)
 Figure 57. Cardiovascular and Cerebrovascular Chinese Patent Medicine Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Research Report 2024
Global Cardiovascular and Cerebrovascular API Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Cerebrovascular Disease Market Research Report 2024
Global Coronary Heart Disease Medication Market Research Report 2025
Global Pre Clinicals Stage Cardiovascular Pipeline Products Market Insights Forecast to 2030
Chinese Patent Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Calcium Channel Blocker Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Calcium Channel Blockers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Myocardial Infarction Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ischemic Cerebrovascular Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cardiovascular Interventional Product Market Research Report 2025
Global Neurovascular Medical Devices Market Research Report 2025
Global Diagnostic Interventional Cardiology Devices Market Insights Forecast to 2030
Global Peptide Based Cardiovascular Therapeutics Market Research Report 2024
Global Cardiovascular and Cerebrovascular Health Food Market Research Report 2024
Cardiovascular Medical Laser Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Interventional Cardiology Instruments Market Insights Forecast to 2030
Cardiovascular Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Coronary Artery Disease Medical Devices Market Research Report 2024
Global Hemorrhagic Stroke Drugs Market Research Report 2025

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions